H. Lee Moffitt Cancer Ctr & Res Inst

18 biology research labs · Tampa, United States. Click a lab to read or write an anonymous review.

• Abate-Daga Labno reviews yet
  NIH R01: Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells,…
• Alexandrow Labno reviews yet
  NIH R01: Direct Control of the human CMG Helicase by Myc and Rb
• Amelio Labno reviews yet
  NIH R01: Role of CRTC1-MAML2 in Salivary Mucoepidermoid Carcinoma Pathobiology
• Avram Labno reviews yet
  NIH R01: Program control of CD8+ T cell response to tumors and tumor memory
• Beg Labno reviews yet
  NIH R01: Defining impact of in situ activation of CD40 and type 1 interferon signaling on theTME and systemic T cell…
• Bonini Labno reviews yet
  NIH R01: A redox-sensitive switch in the macrophage nucleus regulates acute phaseinflammatory injury
• Bortfeld Labno reviews yet
  NIH R01: An Ionizing Radiation Acoustics Imaging (iRAI) Approach for guided Flash Radiotherapy
• Byrd Labno reviews yet
  NIH R01: Body composition and adiposity-associated thromboinflammation in colorectal cancer prognosis
• Carson Labno reviews yet
  NIH R01: Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota…
• Chen Labno reviews yet
  NIH R01: Anti-tumor potential of temperature-sensitive p53 mutants
• Chung Labno reviews yet
  NIH R01: Ultrasensitive detection of circulating DNA methylation for head and neck cancer prognosis
• Cleveland Labno reviews yet
  NIH R01: New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma
• Coghill Labno reviews yet
  NIH R01: HIV Genomic Aging Project in Oncology (HIV-GAP)
• Crowder Labno reviews yet
  NIH R01: The MIND-BC Study: MIND diet for Breast cancer Cognition
• Czerniecki Labno reviews yet
  NIH R01: Remodeling the Immune Landscape in Breast Cancer Leptomeningeal Disease Using Dendritic Cell Therapy is an…
• Da Silva Gomes Labno reviews yet
  NIH R01: Epigenetic and metabolic bottlenecks of tumorigenesis
• Duckett Labno reviews yet
  NIH R01: Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers
• Etame Labno reviews yet
  NIH R01: Targeting Malignant Reprogramming of Glioblastoma Stem Cells Through Dual Inhibition of S6K1 and BIRC3